The AP-1/NF-κB double inhibitor SP100030 can revert muscle wasting during experimental cancer cachexia

International Journal of Oncology

Volumn 30, Issue 5, 2007, Pages 1239-1245

  Moore Carrasco, Rodrigo ^b   Busquets, Sílvia ^a   Almendro, Vanessa ^a   Palanki, Moorthy ^c   López Soriano, Francisco J ^a   Argilés, Josep M ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSIDAD DE TALCA   (Chile)

^c CELGENE CORPORATION   (United States)

Author keywords

AP 1; Cachexia; Nuclear factor B; Skeletal muscle; SP100030

Indexed keywords

ANTINEOPLASTIC AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOSUPPRESSIVE AGENT; ORGANIC COMPOUND; SP 100030; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; BIOSYNTHESIS; CACHEXIA; CHEMISTRY; DRUG ANTAGONISM; EXPERIMENTAL NEOPLASM; GENE EXPRESSION REGULATION; HUMAN; MALE; METABOLISM; MUSCLE; MUSCLE ATROPHY; PATHOLOGY; RAT; WISTAR RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; CACHEXIA; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MUSCLES; MUSCULAR ATROPHY; NEOPLASMS, EXPERIMENTAL; NF-KAPPA B; ORGANIC CHEMICALS; RATS; RATS, WISTAR; TRANSCRIPTION FACTOR AP-1;

EID: 34447306361     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.30.5.1239     Document Type: Article

References (57)

1. Argilés JM, Alvarez B and López-Soriano FJ: The metabolic basis of cancer cachexia. Med Res Rev 17: 477-498, 1997.
2. Studley HO: Percentage of weight loss. A basic indicator of surgical risk in patients with chronic pectic ulcer. JAMA 106: 458-460, 1936.
3. Kern PA and Norton JA: Cancer cachexia. J Parenter Enteral Nutr 12: 286-298, 1988.
4. Costelli P, Carbó N, Tessitore L, Bagby GJ, López-Soriano FJ, Argilés JM and Baccino FM: Tumor necrosis-α mediates changes in tissue protein turnover in a rat cancer cachexia model. J Clin Invest 92: 2783-2789, 1993.
5. García-Martinez C, López-Soriano FJ and Argilés JM: Amino acid uptake in skeletal muscle of rats bearing the Yoshida AH-130 ascites hepatoma. Mol Cell Biochem 148: 17-23, 1995.
6. Llovera M, García-Martínez C, Agell N, López-Soriano FJ and Argilés JM: Muscle wasting associated with cachexia is linked to an important activation of the ATP-dependent ubiquitinmediated proteolysis. Int J Cancer 61: 138-141, 1995.
7. Llovera M, García-Martínez C, Agell N, López-Soriano FJ, Marzabal M and Argilés JM: Ubiquitin gene expression is increased in skeletal muscle of tumour-bearing rats. FEBS Lett 338: 311-318, 1994. (Pubitemid 24056743)
8. Carbó N, Costelli P, Tessitore L, Bagby GJ, López-Soriano FJ, Baccino FM and Argilés JM: Anti-tumour necrosis factor-alpha treatment interferes with changes in lipid metabolism in a tumour cachexia model. Clin Sci 87: 349-355, 1994.
9. Argilés JM, García-Martínez C, Llovera M and López-Soriano FJ: The role of cytokines in muscle wasting: its relation with cancer cachexia. Med Res Rev 12: 637-652, 1992.
10. Garcia-Martinez C, Llovera M, Agell N, Lopez-Soriano FJ and Argiles JM: Ubiquitin gene expression in skeletal muscle is increased during sepsis: involvement of TNF-alpha but not IL-1. Biochem Biophys Res Commun 217: 839-844, 1995.
11. Llovera M, Carbo N, Lopez-Soriano J, Garcia-Martinez C, Busquets S, Alvarez B, Agell N, Costelli P, Lopez-Soriano FJ, Celada A and Argiles JM: Different cytokines modulate ubiquitin gene expression in rat skeletal muscle. Cancer Lett 133: 83-87, 1998. (Pubitemid 29069115)
12. Boes B, Hengel H, Ruppert T, Multhaup G, Koszinowski UH and Kloetzel PM: Interferon gamma stimulation modulates the proteolytic activity and cleavage site preference of 20S mouse proteasomes. J Exp Med 179: 901-909, 1994.
13. Aki M, Shimbara N, Takashina M, Akiyama K, Kagawa S, Tamura T, Tanahashi N, Yoshimura T, Tanaka K and Ichihara A: Interferon-gamma induces different subunit organizations and functional diversity of proteasomes. J Biochem 115: 257-269, 1994.
14. Gaczynska M, Rock KL and Goldberg AL: Gamma-interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes. Nature 365: 264-267, 1993.
15. Costelli P, Llovera M, Carbo N, Garcia-Martinez C, Lopez-Soriano FJ and Argiles JM: Interleukin-1 receptor antagonist (IL-1ra) is unable to reverse cachexia in rats bearing an ascites hepatoma (Yoshida AH-130). Cancer Lett 95: 33-38, 1995.
16. Llovera M, Garcia-Martinez C, Lopez-Soriano J, Carbo N, Agell N, Lopez-Soriano FJ and Argiles JM: Role of TNF receptor 1 in protein turnover during cancer cachexia using gene knockout mice. Mol Cell Endocrinol 142: 183-189, 1998.
17. Llovera M, Garcia-Martinez C, Lopez-Soriano J, Agell N, Lopez-Soriano FJ, Garcia I and Argiles JM: Protein turnover in skeletal muscle of tumour-bearing transgenic mice overexpressing the soluble TNF receptor-1. Cancer Lett 130: 19-27, 1998.
18. Llovera M, Garcia-Martinez C, Lopez-Soriano FJ and Argiles JM: The effect of chronic tumour necrosis factor-alpha treatment on urinary nitrogen excretion in the rat. Biochem Mol Biol Int 33: 681-689, 1994.
19. Argiles JM, Costelli P, Carbo N, Pallares-Trujillo J and Lopez-Soriano FJ: Tumour growth and nitrogen metabolism in the host. Int J Oncol 14: 479-486, 1999.
20. Argiles JM, Busquets S and Lopez-Soriano FJ: Cytokines in the pathogenesis of cancer cachexia. Curr Opin Clin Nutr Metab Care 6: 401-406, 2003.
21. Anker SD, Steinborn W and Strassburg S: Cardiac cachexia. Ann Med 36: 518-529, 2004.
22. van Royen M, Carbo N, Busquets S, Alvarez B, Quinn LS, Lopez-Soriano FJ and Argiles JM: DNA fragmentation occurs in skeletal muscle during tumor growth: A link with cancer cachexia? Biochem Biophys Res Commun 270: 533-537, 2000.
23. Carbo N, Busquets S, van Royen M, Alvarez B, Lopez-Soriano FJ and Argiles JM: TNF-alpha is involved in activating DNA fragmentation in skeletal muscle. Br J Cancer 86: 1012-1016, 2002.
24. Penner CG, Gang G, Wray C, Fischer JE and Hasselgren PO: The transcription factors NF-kappab and AP-1 are differentially regulated in skeletal muscle during sepsis. Biochem Biophys Res Commun 281: 1331-1336, 2001.
25. Agusti A, Morla M, Sauleda J, Saus C and Busquets X: NFkappaB activation and iNOS upregulation in skeletal muscle of patients with COPD and low body weight. Thorax 59: 483-487, 2004. (Pubitemid 38797520)
26. Cai D, Frantz JD, Tawa NE Jr, Melendez PA, Oh BC, Lidov HG, Hasselgren PO, Frontera WR, Lee J, Glass DJ and Shoelson SE: IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. Cell 119: 285-298, 2004.
27. Gerlag DM, Ransone L, Tak PP, Han Z, Palanki M, Barbosa MS, Boyle D, Manning AM and Firestein GS: The effect of a T cell-specific NF-kappa B inhibitor on in vitro cytokine production and collagen-induced arthritis. J Immunol 165: 1652-1658, 2000.
28. Morikawa M, Shorthouse RA, Suto MJ, Goldman ME and Morris RE: A novel inhibitor of nuclear factor-kappa B and activator protein-1 transcription factors in T cells suppresses host-versus-graft alloreactivity in vivo. Transplant Proc 29: 1269-1270, 1997. (Pubitemid 27126190)
29. Tessitore L, Costelli P, Bonetti G and Baccino FM: Cancer cachexia, malnutrition, and tissue protein turnover in experimental animals. Arch Biochem Biophys 306: 52-58, 1993. (Pubitemid 23291282)
30. Busquets S, Alvarez B, Lopez-Soriano FJ and Argiles JM: Branched-chain amino acids: a role in skeletal muscle proteolysis in catabolic states? J Cell Physiol 191: 283-289, 2002.
31. Llovera M, Garcia-Martinez C, Agell N, Lopez-Soriano FJ and Argiles JM: TNF can directly induce the expression of ubiquitin-dependent proteolytic system in rat soleus muscles. Biochem Biophys Res Commun 230: 238-241, 1997. (Pubitemid 27211974)
32. Waalkes TP and Udenfriend S: A fluorometric method for the estimation of tyrosine in plasma and tissues. J Lab Clin Med 50: 733-736, 1957.
33. Blough E, Dineen B and Esser K: Extraction of nuclear proteins from striated muscle tissue. Biotechniques 26: 202-206, 1999. (Pubitemid 29072460)
34. Solanes G, Pedraza N, Iglesias R, Giralt M and Villarroya F: Functional relationship between MyoD and peroxisome proliferator-activated receptor-dependent regulatory pathways in the control of the human uncoupling protein-3 gene transcription. Mol Endocrinol 17: 1944-1958, 2003.
35. Chomczynski P and Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate phenol chloroform extraction. Anal Biochem 162: 156-159, 1987. (Pubitemid 17064313)
36. Bond U and Schlesinger MJ: Ubiquitin is a heat-shock protein in chicken embryo fibroblasts. Mol Cell Biol 5: 949-956, 1985. (Pubitemid 15110282)
37. Warren S: The immediate causes of death in cancer. Am J Med Sci 184: 610-615, 1932.
38. De Wys WD, Begg C, Lavin PT, Band PR, Bennet JM, Bertino JR, Cohen MH, Douglas HO Jr and Engstrom PF: Prognostic effect of weight loss prior to chemotherapy in cancer patiens. Am J Med 69: 491-497, 1980. (Pubitemid 10018703)
39. Todorov PT, Field WN and Tisdale MJ: Role of a proteolysis-inducing factor (PIF) in cachexia induced by a human melanoma (G361). Br J Cancer 80: 1734-1737, 1999.
40. DeJong CH, Busquets S, Moses AG, Schrauwen P, Ross JA, Argiles JM and Fearon KC: Systemic inflammation correlates with increased expression of skeletal muscle ubiquitin but not uncoupling proteins in cancer cachexia. Oncol Rep 14: 257-263, 2005.
41. Kwak KS, Zhou X, Solomon V, Baracos VE, Bannon AW, Davis J, Boyle WJ, Lacey DL and Han HQ: Regulation of protein catabolism by muscle-specific and cytokine-inducible ubiquitin ligase E3alpha-II during cancer cachexia. Cancer Res 64: 8193-8198, 2004. (Pubitemid 39491755)
42. Costelli P, Bossola M, Muscaritoli M, Grieco G, Bonelli G, Bellantone R, Doglietto GB, Baccino FM and Rossi-Fanelli F: Anticytokine treatment prevents the increase in the activity of ATP-ubiquitin- and Ca(2+)-dependent proteolytic systems in the muscle of tumour-bearing rats. Cytokine 19: 1-5, 2002.
43. Alvarez B, Quinn LS, Busquets S, Quiles MT, Lopez-Soriano FJ and Argiles JM: Tumor necrosis factor-alpha exerts interleukin- 6-dependent and -independent effects on cultured skeletal muscle cells. Biochim Biophys Acta 1542: 66-72, 2002.
44. Tsujinaka T, Fujita J, Ebisui C, Yano M, Kominami E, Suzuki K, Tanaka K, Katsume A, Ohsugi Y, Shiozaki H and Monden M: Interleukin 6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin 6 transgenic mice. J Clin Invest 97: 244-249, 1996.
45. Frost RA and Lang CH: Skeletal muscle cytokines: regulation by pathogen-associated molecules and catabolic hormones. Curr Opin Clin Nutr Metab Care 8: 255-263, 2005.
46. Smith HJ, Wyke SM and Tisdale MJ: Role of protein kinase C and NF-kappaB in proteolysis-inducing factor-induced proteasome expression in C(2)C(12) myotubes. Br J Cancer 90: 1850-1857, 2004.
47. Costelli P, Muscaritoli M, Bossola M, Moore-Carrasco R, Crepaldi S, Grieco G, Autelli R, Bonelli G, Lopez-Soriano FJ, Pacelli F, Argiles JM, Doglietto GB, Baccino FM and Rossi Fanelli F: Skeletal muscle wasting in tumor-bearing rats is associated with MyoD down-regulation. Int J Oncol 26: 1663-1668, 2005.
48. Huang TJ, Adcock IM and Chung KF: A novel transcription factor inhibitor, SP100030, inhibits cytokine gene expression, but not airway eosinophilia or hyperresponsiveness in sensitized and allergen-exposed rat. Br J Pharmacol 134: 1029-1036, 2001.
49. Goldman ME, Ransone LJ, Anderson DW, Gaarde WA, Suto MJ, Sullivan RW, Shorthouse R, Morikawa M and Morris RE: SP100030 is a novel T-cell-specific transcription factor inhibitor that possesses immunosuppressive activity in vivo. Transplant Proc 28: 3106-3109, 1996.
50. Costelli P, Tullio RD, Baccino FM and Melloni E: Activation of Ca(2+)-dependent proteolysis in skeletal muscle and heart in cancer cachexia. Br J Cancer 84: 946-950, 2001.
51. Li YP, Chen Y, Li AS and Reid MB: Hydrogen peroxide stimulates ubiquitin-conjugating activity and expression of genes for specific E2 and E3 proteins in skeletal muscle myotubes. Am J Physiol Cell Physiol 285: C806-C812, 2003.
52. Fang CH, Sun X, Li BG, Fischer DR, Pritts TA, Penner G and Hasselgren PO: Burn injuries in rats upregulate the gene expression of the ubiquitin-conjugating enzyme E2(14k) in skeletal muscle. J Burn Care Rehabil 21: 528-534, 2000.
53. Yao T and Cohen RE: Cyclization of polyubiquitin by the E2-25K ubiquitin conjugating enzyme. J Biol Chem 275: 36862-36868, 2000.
54. Gonen H, Bercovich B, Orian A, Carrano A, Takizawa C, Yamanaka K, Pagano M, Iwai K and Ciechanover A: Identification of the ubiquitin carrier proteins, E2s, involved in signal-induced conjugation and subsequent degradation of IkappaBalpha. J Biol Chem 274: 14823-14830, 1999.
55. Pagano M: Cell cycle regulation by the ubiquitin pathway. FASEB J 11: 1067-1075, 1997.
56. Moore-Carrasco R, García-Martínez C, Busquets S, Ametller E, Barreiro E, López-Soriano FJ and Argilés JM: The AP-1/cjun signalling cascade is involved in muscle differentiation: implications in muscle wasting during cancer cachexia. FEBS Lett 580: 691-696, 2006.
57. Argiles JM, Busquets S and Lopez-Soriano FJ: The pivotal role of cytokines in muscle wasting during cancer. Int J Biochem Cell Biol 37: 2036-2046, 2005. (Pubitemid 41213293)